Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib consolidation after autologous stem cell transplantation for multiple myeloma
2008-006751-48Phase 2Completed
- Sponsor
- University College London
- Start
- May 2009
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by University College London. Started May 2009; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2008-006751-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006751-48.